-The Hindu The Empowered Group of Ministers (EGoM) on Food will meet soon following a letter by Union Agriculture Minister Sharad Pawar to Prime Minister Manmohan Singh on curbs over milk, cotton and sugar exports. The EgoM is headed by Union Finance Minister Pranab Mukherjee. Mr. Pawar shot off the letter to the Prime Minister after the EGoM disallowed export of cotton beyond 13 million bales for the current marketing year the...
More »SEARCH RESULT
Not much on the plate by Samar Halarnkar
I have never been to Brazil's "beautiful horizon", Belo Horizonte, the country's third-largest metropolitan area and an information and bio-technology hub, but I have followed the city's progress against what was once its enduring shame: hunger. In 1993, when 11% of its 2.5 million people lived in absolute poverty and a fifth of Belo's children went hungry, a newly-elected government declared that food was a fundamental right of every citizen,...
More »23 guilty in Gujarat riot case by Basant Rawat
A Gujarat court today convicted 23 of the 46 accused in a 2002 riot case in which a mob torched a house where four families had taken shelter, killing 23 people. The court in Anand district will hand down the sentences on April 12 in the so-called “Ode massacre” or “Pirawali massacre”, one of the nine cases probed by the Supreme Court-appointed special investigation team (SIT). This is the third Gujarat riot...
More »A Strike against Pharma MNCs
-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines. The German pharmaceutical company Bayer holds the patent...
More »A life saver-Shamnad Basheer
Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...
More »